tirzepatide conversion Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are tirzepatide dosage units conversion Pharmacy

doi: 10.1016/j.stem.2019.08.015 238 NeumannH.KotterM

The combination of monthly dosing, a new indication category (neuroscience instead of cardiometabolic), and the broader GLP-1-and-addiction signal is the most interesting pipeline development in this class right now

Smoothies and Juices: Blend the rind with other fruits, such as strawberries and lemons, to create a refreshing and nutritious drink

Many studies have shown that the gut microbiota plays a crucial role in brain function and changes in the behavior of individuals and the formation of bacterial amyloids

NHS access and guidance In England, Scotland, and Wales, Wegovy is commissioned through specialist weight-management services under NICE TA875